According to research report the clinical microbiology market is expected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018 growing at a CAGR of 6.4% during forecast period. Asia Pacific market is expected to grow at the highest CAGR from 2018 to 2023.
The global clinical microbiology market is segmented by product, disease area, end user, and region. On the basis of products, the clinical microbiology market is segmented into instruments, and reagents.
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219135367
• The key players in the industry and markets have been identified through extensive secondary research.
• The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
• All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Coverage of new market players, change in market share of existing players
Company profiles offer a glimpse into the workings of key players in the market with respect to business overview, financials, product offerings, and recent developments. In the new edition of the report includes microbiology testing product manufacturers such as QIAGEN N.V. (The Netherlands), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Shimadzu Corporation (Japan), 3M Company (US), and Neogen Corporation (US). These companies have been profiled as they have emerged as key players in recent time due to the various strategic investments, agreements, and product launches in the microbiology testing space. These strategic developments have challenged the status quo of industry leaders and it was prudent to analyze the changing business landscape.
Updated financial information/ product portfolio of players
Newer and improved representation of financial information: In the latest edition of the microbiology testing/clinical microbiology market report, the market share analysis of top players in the clinical microbiology market has been provided for base year (2017) by extensively studying the financial revenues generated by the major players operating in the clinical microbiology market. The new edition of the report also provides updated financial information in the context of microbiology testing/clinical microbiology market till 2017 for each listed company via a graphical representation in a single diagram (instead of multiple tables). This will help readers to easily analyze the present status of profiled companies in terms of their financial strength, profitability, key revenue generating region/country, and business segment focus (in terms of the highest revenue-generating segment and investment on research and development activities).